News 2015
Three Tips for Redesigning a Website for the HIV and Hepatitis Communities
Website collaboration
Earlier this year, the National Alliance of State & Territorial AIDS Directors (NASTAD) launched a new website to enhance our communication with state health department staff who implement HIV and hepatitis programs in the United States. The website redesign is one outcome of our work to develop a communications strategy that is responsive to the ever-evolving needs of our stakeholders, including health departments' staff, funders, and national partners.
Read more: Three Tips for Redesigning a Website for the HIV and Hepatitis Communities
HUD and Department of Labor Launch Training Curriculum for HIV/AIDS Housing and Service Providers
Moving Day
WASHINGTON – The U.S. Department of Housing and Urban Development's (HUD) Office of HIV/AIDS Housing, in collaboration with the U.S. Department of Labor's (DOL) Office of Disability Employment Policy (ODEP), has unveiled a new training curriculum for HIV/AIDS housing and service providers focused on employment services.
In This Issue
This is a really, really exciting time for the Black AIDS Institute, as we expand our services and partnerships to end the epidemic in Black communities. In this issue, we'd like to introduce you to two new members of the Institute's team: our prevention and care manager, Christopher Wilson-Smith, and mobilization manager, Darriane Martin.
The Path to a Cure for Hepatitis C in People with HIV
Shyam Kottilil, M.D., Ph.D., Professor of Medicine, Division of Clinical Care and Research; Associate Chief, Division of Clinical Care and Research; and Co-director, Clinical Trials Unit, Institute of Human Virology
Hepatitis C can be a chronic condition that leads to liver failure, and treatments often haven't worked for patients who are also co-infected with HIV. Thanks to research led by the National Institute of Allergy and Infectious Diseases and Gilead Sciences, new therapies are now available that can cure even complicated cases of hepatitis C without serious side effects. Read on to learn how these discoveries were made and what they mean for patients around the world.
No Easy Feat: Promoting The PrEP Pill For HIV Prevention Among Latinos
Louis Arevalo holds his Truvada pills at his home in Los Angeles, California. The drug Truvada, used to halt HIV infection, has been shown to be over 90 percent effective when used correctly.
LOS ANGELES – Late on a Friday night at The New Jalisco Bar downtown, a drag show featuring dancers dressed in sequined leotards and feathered headdresses had drawn a crowd — most of them gay Latino men.
Inside the bar and out, three health workers chatted with customers, casually asking questions: Do you know about the HIV prevention pill? Would you consider taking it? A few men said they had never heard of it. Others simply said it wasn't for them.